GLP1R and ischemia: Hausenloy et al. also showed that chronic treatment with DPP-4 inhibitors reduce infarct size via the GLP-1R-protein kinase A pathway, in a glucose dependent manner in vivo rat models and confirmed the cardioprotective action of the endogenous intact GLP-1 on ischemia/reperfusion injury [31].